Sharda Cropchem Intrinsic Value
Sharda Cropchem (SHARDACROP) median intrinsic value is ₹911.59 from 9 valuation models (range ₹349–₹1870), vs current price ₹934.80 — -2.5% downside (Trading Near Calculated Value), margin of safety -2.5%. Browse SHARDACROP cash flow statement for revenue, profit, balance sheet and cash flow data.
SHARDACROP Valuation Methods Summary — DCF, Graham Number & P/E
Sharda Cropchem intrinsic value across 9 models vs current price ₹934.80 — upside/downside and value range per method. Also explore SHARDACROP share price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1695.36 | ₹1356.29 - ₹2034.43 | +81.4% | EPS: ₹141.28, Sector P/E: 12x |
| Book Value Method | asset | ₹348.56 | ₹313.70 - ₹383.42 | -62.7% | Book Value/Share: ₹348.56, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹742.04 | ₹667.84 - ₹816.24 | -20.6% | Revenue/Share: ₹927.56, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1360.00 | ₹1224.00 - ₹1496.00 | +45.5% | EBITDA: ₹2040.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹911.59 | ₹729.27 - ₹1093.91 | -2.5% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹904.19 | ₹813.77 - ₹994.61 | -3.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1164.15 | ₹1047.74 - ₹1280.57 | +24.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1869.60 | ₹1682.64 - ₹2056.56 | +100.0% | ROE: 40.7%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹697.11 | ₹627.40 - ₹766.82 | -25.4% | EPS: ₹141.28, BVPS: ₹348.56 |
SHARDACROP Intrinsic Value vs Market Price — All Valuation Models
Sharda Cropchem fair value range ₹349–₹1870 vs current market price ₹934.80 across 9 valuation models. For current market price and key ratios, visit SHARDACROP share price screener.
SHARDACROP Intrinsic Value Analysis — Undervalued or Overvalued?
Sharda Cropchem median intrinsic value ₹911.59, current price ₹934.80 — Trading Near Calculated Value by 2.5%, margin of safety -2.5%.
What is the intrinsic value of SHARDACROP?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sharda Cropchem (SHARDACROP) is ₹911.59 (median value). With the current market price of ₹934.80, this represents a -2.5% variance from our estimated fair value.
The valuation range spans from ₹348.56 to ₹1869.60, indicating ₹348.56 - ₹1869.60.
Is SHARDACROP undervalued or overvalued?
Based on our multi-method analysis, Sharda Cropchem (SHARDACROP) appears to be trading near calculated value by approximately 2.5%.
SHARDACROP Financial Health — Key Ratios vs Industry Benchmarks
Sharda Cropchem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.27 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 40.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 24.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.44x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SHARDACROP Cash Flow Quality — Operating & Free Cash Flow
Sharda Cropchem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹604 Cr | ₹356 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹341 Cr | ₹145 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹328 Cr | ₹272 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹267 Cr | ₹165 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹246 Cr | ₹105 Cr | Positive Free Cash Flow | 7/10 |